Apollo to Present at Barclays 22nd Annual Global Financial Services Conference
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Scott Kleinman, Co-President of Apollo Asset […]
Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress
ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for […]
TSX News -
G2 Expands New Gold Zones at OKO – 57.5m @ 4.3 g/t Au, 38.2m @ 3.4 g/t Au & 69.5m @ 1.9 g/t Au
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX: GTWO; OTCQX: GUYGF) is pleased […]
Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval […]
DT Cloud Acquisition Corporation Signs Letter of Intent for a Business Combination
New York, New York, Sept. 03, 2024 (GLOBE NEWSWIRE) — DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (the “Company”) […]
Trust Stamp Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market, for Aggregate Gross Proceeds of $2.0 Million
Atlanta, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered software used […]
VCI Global Secures Approximately US$18 Million Contract for IPO Deals
KUALA LUMPUR, Malaysia, Sept. 03, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global,” “VCIG,” or […]
Y-mAbs to Participate in Upcoming Investor Conferences in September
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]
H&R Block Names Andy Phillips as New Vice President of The Tax Institute
KANSAS CITY, Mo., Sept. 03, 2024 (GLOBE NEWSWIRE) — H&R Block, Inc. (NYSE: HRB), a leading provider of global tax […]
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s […]
